Related Experiment Video
Updated: Mar 8, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Dysregulation of the miR-194-CUL4B negative feedback loop drives tumorigenesis in non-small-cell lung carcinoma
Jun Mi1,2, Yongxin Zou1, Xiaohua Lin1
1The Key Laboratory of Experimental Teratology, Ministry of Education and Department of Molecular Medicine and Genetics, Shandong University School of Basic Medical Sciences, Jinan, China.
Abstract:
Cullin 4B (CUL4B), a scaffold protein that assembles CRL4B ubiquitin ligase complexes, is overexpressed in many types of cancers and represses many tumor suppressors through epigenetic mechanisms. However, the mechanisms by which CUL4B is upregulated remain to be elucidated. Here, we show that CUL4B is upregulated in non-small-cell lung carcinoma (NSCLC) tissues and is critically required for cell proliferation and migration in vitro and for xenograft tumor formation in vivo. We found that microRNA-194 (miR-194) and CUL4B protein were inversely correlated in cancer specimens and demonstrated that miR-194 could downregulate CUL4B by directly targeting its 3'-UTR. We also showed that CUL4B could be negatively regulated by p53 in a miR-194-dependent manner. miR-194 was further shown to attenuate the malignant phenotype of lung cancer cells by downregulating CUL4B. Interestingly, CRL4B also epigenetically represses miR-194 by catalyzing monoubiquitination at H2AK119 and by coordinating with PRC2 to promote trimethylation at H3K27 at the gene clusters encoding miR-194. RBX1, another component in CRL4B complex, is also targeted by miR-194 in NSCLC cells. Our results thus establish a double-negative feedback loop between miR-194 and CRL4B, dysregulation of which contributes to tumorigenesis. The function of miR-194 as a negative regulator of CUL4B has therapeutic implications in lung cancer.
Insights
MicroRNA-194 (miR-194) suppresses non-small cell lung cancer (NSCLC) by targeting Cullin 4B (CUL4B). A feedback loop between miR-194 and CRL4B contributes to lung tumorigenesis, offering therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Cullin 4B (CUL4B) is overexpressed in cancers, repressing tumor suppressors via epigenetic mechanisms.
- Mechanisms of CUL4B upregulation are not fully understood.
- CUL4B is a scaffold protein assembling CRL4B ubiquitin ligase complexes.
Purpose of the Study:
- Investigate CUL4B upregulation in non-small cell lung carcinoma (NSCLC).
- Elucidate the regulatory relationship between miR-194 and CUL4B in NSCLC.
- Determine the role of the miR-194/CUL4B axis in lung cancer progression.
Main Methods:
- Correlation analysis of miR-194 and CUL4B in NSCLC tissues.
- Luciferase reporter assays to confirm direct targeting of CUL4B 3'-UTR by miR-194.
- In vitro and in vivo assays to assess CUL4B's role in NSCLC proliferation, migration, and tumor formation.
- Chromatin immunoprecipitation (ChIP) assays to investigate CRL4B-mediated epigenetic repression of miR-194.
Main Results:
- CUL4B is upregulated in NSCLC and promotes proliferation, migration, and tumor growth.
- miR-194 directly targets and downregulates CUL4B, with an inverse correlation observed in patient samples.
- CRL4B epigenetically represses miR-194 via H2AK119 monoubiquitination and H3K27 trimethylation, establishing a double-negative feedback loop.
- RBX1, a CRL4B component, is also targeted by miR-194.
Conclusions:
- A feedback loop between miR-194 and CRL4B, involving epigenetic regulation, is dysregulated in NSCLC.
- miR-194 acts as a tumor suppressor by downregulating CUL4B.
- Targeting the miR-194/CUL4B axis presents a potential therapeutic strategy for NSCLC.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic...
Negative Regulator Molecules

